Access the full text.
Sign up today, get DeepDyve free for 14 days.
Balls Michael, A. Patrick, Bremer Susanne, Casati Silvia, Coecke Sandra, Clothier Richard, Combes Robert, Corvi Raffaella, C. Rodger, Eskes Chantra, F. Julia, Gribaldo Laura, H. Maria, Hartung Thomas, Hoffmann Sebastian, S. Leonard, S. Laurie, S. Horst, Stokes William, T. Raymond, W. Drew, Z. Valerie (2006)
The Principles of Weight of Evidence Validation of Test Methods and Testing Strategies
Balls Michael, Blaauboer j., F. helen, Bruner Leon, C. D., E. Bjorn, Fielder Robin, Guillonzo Andre, L. Richard, Lovell David, R. Christoph, Sladowski Dariusz, S. Horst, Zucco Flavia (1995)
Practical Aspects of the Validation of Toxicity Test Procedures
Innovation Stagnation (2004)
Challenge and Opportunity on the Critical Path to New Medical Products
H. Anders, V. Vielhauer (2007)
Identifying and validating novel targets with in vivo disease models: guidelines for study design.Drug discovery today, 12 11-12
Andrew Worth, M. Balls (2002)
The principles of validation and the ECVAM validation process.Alternatives to laboratory animals : ATLA, 30 Suppl 2
A. Markou, C. Chiamulera, M. Geyer, M. Tricklebank, T. Steckler (2009)
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal ModelsNeuropsychopharmacology, 34
S. Hoffmann, L. Edler, I. Gardner, L. Gribaldo, T. Hartung, C. Klein, M. Liebsch, S. Sauerland, L. Schechtman, A. Stammati, E. Nikolaidis (2008)
Points of Reference in the Validation ProcessAlternatives to Laboratory Animals, 36
H. Barnhart, M. Haber, L. Lin (2007)
An Overview on Assessing Agreement with Continuous MeasurementsJournal of Biopharmaceutical Statistics, 17
Alan Regenberg, Debra Mathews, David Blass, H. Bok, Joseph Coyle, Patrick Duggan, R. Faden, J. Finkel, John Gearhart, A. Hillis, A. Hoke, Richard Johnson, M. Johnston, J. Kahn, Douglas Kerr, Patricia King, J. Kurtzberg, S. Liao, John McDonald, G. McKhann, Karin Nelson, Mahendra Rao, Andrew Siegel, Kirby Smith, D. Solter, Hongjun Song, J. Sugarman, A. Vescovi, Wise Young, H. Greely, R. Traystman (2009)
The Role of Animal Models in Evaluating Reasonable Safety and Efficacy for Human Trials of Cell-Based Interventions for Neurologic ConditionsJournal of Cerebral Blood Flow & Metabolism, 29
N. Bhogal, M. Balls (2008)
Translation of new technologies: from basic research to drug discovery and development.Current drug discovery technologies, 5 3
K. Miczek (2008)
Challenges for Translational Psychopharmacology Research: The Need for Conceptual Principles
M. Balls, P. Amcoff, S. Bremer, S. Casati, S. Coecke, R. Clothier, R. Combes, R. Corvi, R. Curren, C. Eskes, J. Fentem, L. Gribaldo, M. Halder, T. Hartung, S. Hoffmann, L. Schechtman, Laurie Scott, H. Spielmann, W. Stokes, R. Tice, Drew Wagner, V. Zuang (2006)
The Principles of Weight of Evidence Validation of Test Methods and Testing StrategiesAlternatives to Laboratory Animals, 34
F. Staay (2006)
Animal models of behavioral dysfunctions: Basic concepts and classifications, and an evaluation strategyBrain Research Reviews, 52
M. Balls, B. Blaauboer, J. Fentem, L. Bruner, R. Combes, B. Ekwall, R. Fielder, A. Guillouzo, Richard Lewis, D. Lovell, C. Reinhardt, G. Repetto, D. Šladowski, H. Spielmann, F. Zucco (1995)
Practical Aspects of the Validation of Toxicity Test ProceduresAlternatives to Laboratory Animals, 23
D. Dam, P. Deyn (2006)
Model organisms: Drug discovery in dementia: the role of rodent modelsNature Reviews Drug Discovery, 5
Andrew Worth, M. Balls (2002)
The Principles of Validation and the ECVAM Validation ProcessAlternatives to Laboratory Animals, 32
T. Hartung, S. Bremer, S. Casati, S. Coecke, R. Corvi, S. Fortaner, L. Gribaldo, M. Halder, S. Hoffmann, A. Roi, P. Prieto, E. Sabbioni, Laurie Scott, Andrew Worth, V. Zuang (2004)
A Modular Approach to the ECVAM Principles on Test ValidityAlternatives to Laboratory Animals, 32
The use of animals to model humans in biomedical research relies on the notion that basic processes are sufficiently similar across species to allow extrapolation. Animal model validity is discussed in terms of the similarity between the model and the human condition it is intended to model, but no formal validation of models is applied. There is a stark contrast here with the use of non-animal alternatives in toxicology and safety studies, for which an extensive validation is required. We discuss both the potential and the limitations of validating preclinical animal models for proof-of-concept studies, by using an approach similar to that applied to alternative non-animal methods in toxicology and safety testing. A major challenge in devising a validation system for animal models is the lack of a clear gold standard with which to compare results. While a complete adoption of the validation approach for alternative methods is probably inappropriate for research animal models, key features, such as making data available for external validation and defining a strategy to run experiments in a way that permits meaningful retrospective analysis, remain highly relevant.
Alternatives to Laboratory Animals – SAGE
Published: Jun 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.